Trimethylglycine (TMG): Difference between revisions

    From Longevity Wiki
    No edit summary
    Line 3: Line 3:
    Although trimethylglycine supplementation decreases the amount of [[wikipedia:Adipose_tissue|adipose tissue]] in pigs, research on human subjects has shown no effect on body weight, body composition, or resting energy expenditure when used in conjunction with a low calorie diet.<ref name="pmid12399266">{{cite journal|last1=Schwab|volume=76|doi-access=free|doi=10.1093/ajcn/76.5.961|pmid=12399266|date=November 2002|pages=961–967|issue=5|journal=Am. J. Clin. Nutr.|first1=U.|title=Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects|display-authors=etal|first3=L.|last3=Toppinen|first2=A.|last2=Törrönen|title-link=doi}}</ref>
    Although trimethylglycine supplementation decreases the amount of [[wikipedia:Adipose_tissue|adipose tissue]] in pigs, research on human subjects has shown no effect on body weight, body composition, or resting energy expenditure when used in conjunction with a low calorie diet.<ref name="pmid12399266">{{cite journal|last1=Schwab|volume=76|doi-access=free|doi=10.1093/ajcn/76.5.961|pmid=12399266|date=November 2002|pages=961–967|issue=5|journal=Am. J. Clin. Nutr.|first1=U.|title=Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects|display-authors=etal|first3=L.|last3=Toppinen|first2=A.|last2=Törrönen|title-link=doi}}</ref>


    = Protective Effects =
    = Positiv Effects =
    Protective effects of TMG in experimental animal models, cell culture systems, and clinical studies. Removed ADL and MAFLD
    Protective effects of TMG in experimental animal models, cell culture systems, and clinical studies.
    {| class="wikitable"
    {| class="wikitable"
    ! colspan="1" rowspan="1" |Therapeutic Effects of TMG Administration
    ! colspan="1" rowspan="1" |Therapeutic Effects of TMG Administration
    Line 10: Line 10:
    ! colspan="1" rowspan="1" |Authors
    ! colspan="1" rowspan="1" |Authors
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Prevents hepatic fat accumulation in ALD
    | colspan="1" rowspan="1" |Male Wistar rats; C57BL/6 mice; Balb/c mice
    | colspan="1" rowspan="1" |Male Wistar rats; C57BL/6 mice; Balb/c mice
    | colspan="1" rowspan="1" |[23,27,83,115,121,157,158,160]
    | colspan="1" rowspan="1" |[23,27,83,115,121,157,158,160]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Preserves/restores hepatic SAM: SAH ratios by regenerating SAM and lowering SAH and homocysteine levels in ALD
    | colspan="1" rowspan="1" |Male Wistar rats; hepatocytes; male C57BL/6 mice
    | colspan="1" rowspan="1" |Male Wistar rats; hepatocytes; male C57BL/6 mice
    | colspan="1" rowspan="1" |[23,60,61,81,82,83,84,86,88,91,92,117,119,121,234,235]
    | colspan="1" rowspan="1" |[23,60,61,81,82,83,84,86,88,91,92,117,119,121,234,235]
    Line 22: Line 22:
    | colspan="1" rowspan="1" |[23,90,91,92]
    | colspan="1" rowspan="1" |[23,90,91,92]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Suppresses the synthesis of DGAT2, a rate-limiting enzyme in triglyceride synthesis, by alleviating ERK1/2 inhibition in ALD
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |[121]
    | colspan="1" rowspan="1" |[121]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Upregulates antioxidant defense system and improves oxyradical scavenging activity in ALD
    | colspan="1" rowspan="1" |Male Wistar rats
    | colspan="1" rowspan="1" |Male Wistar rats
    | colspan="1" rowspan="1" |[133]
    | colspan="1" rowspan="1" |[133]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Prevents/attenuates ER stress in ALD
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |[83]
    | colspan="1" rowspan="1" |[83]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Exerts hepatoprotection by preserving mitochondrial function in ALD
    | colspan="1" rowspan="1" |Male Wistar rats
    | colspan="1" rowspan="1" |Male Wistar rats
    | colspan="1" rowspan="1" |[61]
    | colspan="1" rowspan="1" |[61]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Restores the serum adiponectin levels in ALD
    | colspan="1" rowspan="1" |Mice
    | colspan="1" rowspan="1" |Mice
    | colspan="1" rowspan="1" |[123]
    | colspan="1" rowspan="1" |[123]
    Line 46: Line 46:
    | colspan="1" rowspan="1" |[115,133]
    | colspan="1" rowspan="1" |[115,133]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Prevents serum ALT and AST activity elevations in models of ALD and MAFLD
    | colspan="1" rowspan="1" |Male Wistar rats
    | colspan="1" rowspan="1" |Male Wistar rats
    | colspan="1" rowspan="1" |[27,115,121]
    | colspan="1" rowspan="1" |[27,115,121]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Reduces liver oxidant stress, inflammation, and apoptosis in MAFLD
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |[28]
    | colspan="1" rowspan="1" |[28]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Remethylates homocysteine, protecting from oxidant stress and restoring phosphatidylcholine generation in MAFLD
    | colspan="1" rowspan="1" |C57BL/6 mice
    | colspan="1" rowspan="1" |C57BL/6 mice
    | colspan="1" rowspan="1" |[161]
    | colspan="1" rowspan="1" |[161]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Stimulates β-oxidation in livers of MCD diet-induced MAFLD
    | colspan="1" rowspan="1" |Male Sprague-Dawley rats
    | colspan="1" rowspan="1" |Male Sprague-Dawley rats
    | colspan="1" rowspan="1" |[162]
    | colspan="1" rowspan="1" |[162]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Alleviates steatosis and increases autophagosomes numbers in mouse livers with MAFLD
    | colspan="1" rowspan="1" |Male C57BL/6 mice; rats
    | colspan="1" rowspan="1" |Male C57BL/6 mice; rats
    | colspan="1" rowspan="1" |[120,161]
    | colspan="1" rowspan="1" |[120,161]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Enhances the conversion of existing WAT to brown adipose tissue through stimulating mitochondrial biogenesis in MAFLD
    | colspan="1" rowspan="1" |Mice
    | colspan="1" rowspan="1" |Mice
    | colspan="1" rowspan="1" |[203]
    | colspan="1" rowspan="1" |[203]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Alleviates ROS-induced mitochondrial respiratory chain dysfunction in MAFLD
    | colspan="1" rowspan="1" |Male Sprague-Dawley rats
    | colspan="1" rowspan="1" |Male Sprague-Dawley rats
    | colspan="1" rowspan="1" |[163].
    | colspan="1" rowspan="1" |[163].
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Attenuates different grades of steatosis, inflammation, and fibrosis in MAFLD patients
    | colspan="1" rowspan="1" |Human trials
    | colspan="1" rowspan="1" |Human trials
    | colspan="1" rowspan="1" |[45,165,166,167]
    | colspan="1" rowspan="1" |[45,165,166,167]
    |-
    |-
    | colspan="1" rowspan="1" |
    | colspan="1" rowspan="1" |Prevents adipose tissue dysfunction in ALD
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |Male C57BL/6 mice
    | colspan="1" rowspan="1" |[194]
    | colspan="1" rowspan="1" |[194]

    Revision as of 03:13, 22 September 2023

    Trimethylglycine, commonly known as TMG or betaine, is an amino acid derivative that naturally occurs in various plant and animal sources. With its three methyl groups attached to a glycine molecule, TMG has garnered attention in both the dietary supplement market and the scientific community due to its role as a methyl donor in vital biochemical processes.

    Although trimethylglycine supplementation decreases the amount of adipose tissue in pigs, research on human subjects has shown no effect on body weight, body composition, or resting energy expenditure when used in conjunction with a low calorie diet.[1]

    Positiv Effects

    Protective effects of TMG in experimental animal models, cell culture systems, and clinical studies.

    Therapeutic Effects of TMG Administration Experimental Model Authors
    Prevents hepatic fat accumulation in ALD Male Wistar rats; C57BL/6 mice; Balb/c mice [23,27,83,115,121,157,158,160]
    Preserves/restores hepatic SAM: SAH ratios by regenerating SAM and lowering SAH and homocysteine levels in ALD Male Wistar rats; hepatocytes; male C57BL/6 mice [23,60,61,81,82,83,84,86,88,91,92,117,119,121,234,235]
    Restores activities of various liver methyltransferases (PEMT, ICMT, PIMT, PRMT) to increase phosphatidylcholine levels, preventing apoptosis and accumulation of damaged proteins, and restoring proteasome activity Male Wistar rats; hepatocytes [23,90,91,92]
    Suppresses the synthesis of DGAT2, a rate-limiting enzyme in triglyceride synthesis, by alleviating ERK1/2 inhibition in ALD Male C57BL/6 mice [121]
    Upregulates antioxidant defense system and improves oxyradical scavenging activity in ALD Male Wistar rats [133]
    Prevents/attenuates ER stress in ALD Male C57BL/6 mice [83]
    Exerts hepatoprotection by preserving mitochondrial function in ALD Male Wistar rats [61]
    Restores the serum adiponectin levels in ALD Mice [123]
    Prevents elevations of CD14, TNFα, COX2, GADD45β, LITAF, JAK3, TLR2, TLR4, IL1β, and PDCD4 and NOS2 mRNA levels in alcoholic liver injury Male Wistar rats [115,133]
    Prevents serum ALT and AST activity elevations in models of ALD and MAFLD Male Wistar rats [27,115,121]
    Reduces liver oxidant stress, inflammation, and apoptosis in MAFLD Male C57BL/6 mice [28]
    Remethylates homocysteine, protecting from oxidant stress and restoring phosphatidylcholine generation in MAFLD C57BL/6 mice [161]
    Stimulates β-oxidation in livers of MCD diet-induced MAFLD Male Sprague-Dawley rats [162]
    Alleviates steatosis and increases autophagosomes numbers in mouse livers with MAFLD Male C57BL/6 mice; rats [120,161]
    Enhances the conversion of existing WAT to brown adipose tissue through stimulating mitochondrial biogenesis in MAFLD Mice [203]
    Alleviates ROS-induced mitochondrial respiratory chain dysfunction in MAFLD Male Sprague-Dawley rats [163].
    Attenuates different grades of steatosis, inflammation, and fibrosis in MAFLD patients Human trials [45,165,166,167]
    Prevents adipose tissue dysfunction in ALD Male C57BL/6 mice [194]
    Reduces the inflammatory adipokines, IL6, TNFα, and leptin in human adipocytes Human visceral adipocytes [204]
    Inhibits lipid peroxidation, hepatic inflammation, and expression of transforming growth factor-β1 in liver fibrosis Male chicks [148]
    Suppresses alcoholic liver fibrosis Rats [116]
    Prevents the formation of Mallory–Denk bodies through epigenetic means by attenuating the decrease of MAT1A, SAHH, BHMT, and AMD1 expression C3H male mice [138]
    Reverses the inhibitory effects of acetaldehyde on IFN signaling and decreases de-methylation of STAT1 by JMJD6 HCV-infected Huh7.5 CYP2E1 (+) cells and human hepatocytes [141,143]
    Enhances expression of PPARα and elevates fatty acid catabolism Male C57BL/6 and ApoE−/− mice [158].
    Inhibits lipogenic activity in liver by activation of AMPK ApoE−/− mice; Male C57BL/6 mice [159,160]
    Regulates colonic fluid balance Rats [21,200]
    Improves intestinal barrier function and maintains the gut microbiota Porcine epithelial cells; Caco-2 cells; rat small intestinal cell line IEC-18 [22,197,198]
    Activates GI digestive enzymes and ameliorates intestinal morphology and microbiota dysbiosis Male Sprague Dawley rats [200]
    Attenuates alcoholic-induced pancreatic steatosis Male Wistar rats [125]
    Associated with resilience to anhedonia and prevention of stress-related psychiatric disorders Male C57BL/6 mice [218]
    Treats asthma-induced oxidative stress, thus improving airway function of lung tissue BALB/C mice [207]
    Protects against cadmium nephrotoxicity Male Wistar rats [206]
    Protects against isoprenaline-induced myocardial dysfunction Male Wistar rats [205]
    Anti-nociceptive and sedative role via interactions with opioidergic and GABA receptors Male albino mice [220]
    Normalizes fetal growth and reduces adiposity of progeny from obese mice C57BL/6J mice [229]
    Anti-cancer effect in alcohol-associated breast cancer cell growth and development Breast adenocarcinoma cell line (MCF-7) [213]
    Reduces rectal temperature in broiler chickens Chickens [226,227]
    Improves post-natal lamb survival Lambs [230]

    Taking TMG

    Side effects

    Trimethylglycine supplementation may cause diarrhea, bloating, cramps, dyspepsia, nausea or vomiting.[2] Although rare, it can also causes excessive increases in serum methionine concentrations in the brain, which may lead to cerebral edema, a life-threatening condition.[2]

    Trimethylglycine supplementation lowers homocysteine but also raises LDL-cholesterol in obese individuals and renal patients.[3]

    References

    1. Schwab et al.; "Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects" , https://doi.org/10.1093/ajcn/76.5.961
    2. 2.0 2.1 "Betaine" , LiverTox: Clinical and Research Information on Drug-Induced Liver Injury , National Institute of Diabetes and Digestive and Kidney Diseases , http://www.ncbi.nlm.nih.gov/books/NBK548774/
    3. Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB; "Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans" , https://doi.org/10.1371/journal.pmed.0020135